International Symposium on the Pathophysiology of Developmental and Epileptic Encephalopathy (ISDEE2020) (The 21st Annual Meeting of the Infantile Seizure Society)
Virtual meeting
19 - 21 June 2020
ILAE Curriculum Learning Objectives addressed by this course
- 1.1.1 Describe the major etiologies for epilepsy (i.e. structural, genetic, infectious, metabolic, immune, and neurodegenerative) (L1)
- 1.1.2 Describe the common structural etiologies
- 1.1.3 Describe the common genetic causes of epilepsy
- 1.1.4 Describe the common infectious causes of epilepsy, including geographical impacts (e.g. bacterial, fungal, viral, parasites) (L2)
- 1.1.5 Describe the common metabolic causes of epilepsy
- 1.1.6 Describe the common immune causes of epilepsy
- 1.1.7 Describe the common neurodegenerative causes of epilepsy
- 1.2.1 Decide on which patients to do genetic testing (L2)
- 1.2.2 Decide what type of genetic testing to conduct (L3)
- 1.2.3 Interpret and apply the results of genetic testing accurately in the clinical context (L3)
- 1.3.1 Learn and recognize the seizure semiology and distinguish it from other non-epileptic manifestations
- 1.3.2 Extract semiology information from patient history
- 1.3.3 Extract semiology information from video recordings
- 1.3.4 Interpret semiological signs and symptoms allowing hypotheses on the localization of focal seizures
- 1.3.5 Interpret semiological signs and symptoms suggesting focal vs. generalized onset
- 1.3.6 Classify seizures according to the ILAE classification
- 1.4.10 Recognize and describe ictal patterns (L2)
- 1.4.11 Recognize and describe ictal and interictal patterns with intracranial recordings (L3)
- 1.4.9 Recognize and describe interictal abnormalities (L2)
- 1.5.1 Recognize the spectrum of MRI sequences optimized for epilepsy (L2)
- 1.5.2 Decide on whom to do structural neuroimaging (L1)
- 1.5.3 Decide when to conduct neuroimaging and repeat as needed (L2)
- 1.5.4 Decide when to conduct specialized neuroimaging and which type
- 1.5.5 Interpret and apply the results of specialized neuroimaging accurately in the clinical context (L3)
- 1.6.1 Decide which patients should receive lab tests and which types of tests should be ordered (L1)
- 1.7.1 Accurately distinguish acute symptomatic seizures from epilepsy (L1)
- 1.7.2 Correctly distinguish between focal and generalized epilepsies and recognize epileptic encephalopathies (L1)
- 1.7.3 Correctly diagnose and classify focal epilepsies (L2)
- 1.7.4 Correctly diagnose and classify generalized epilepsies (L1)
- 1.7.5 Correctly diagnose and classify combined focal and generalized epilepsies including epileptic encephalopathy (L2)
- 2.2.1 Provide guidance on social issues including school integration, work, legal, and related aspects (L1)
- 2.3.1 Communicate to patients and families as appropriate (L1)
- 2.3.2 Educate patients and family about the disease specifics (L2)
- 2.3.3 Educate caregivers about the clinical condition and its management (L2)
- 2.3.4 Educate workplace or school stakeholders concerning the patient's needs (L3)
- 2.3.5 Provide information to patients regarding potential adverse effects of antiepileptic drugs (L1)
- 2.3.6 Counsel patients and family regarding the risks and benefits of epilepsy surgery (L3)
- 2.4.2 Advise patients with uncontrolled seizures (L2)
- 2.5.1 Recognize when to refer patients for higher level of care (L1)
- 2.9.1 Provide counseling specific to children with epilepsy and their parents, according to the epilepsy-types (L2)
- 3.1.1 Identify the spectrum of action for antiepileptic drugs (L1)
- 3.1.2 Demonstrate knowledge of pharmacokinetics and pharmacodynamics (L1)
- 3.1.3 Demonstrate knowledge regarding the adverse effects of antiepileptic drugs (L1)
- 3.1.4 Demonstrate knowledge of appropriate monitoring of AES serum levels (L2)
- 3.1.5 Demonstrate knowledge about drug interactions (e.g. enzyme induction, etc.) for AED/AED and AED/concomitant medication
- 3.1.6 Demonstrate knowledge about treatment of psychiatric and cognitive comorbidities in children and adults (L3)
- 3.2.1 Recommend appropriate therapy according to seizure type (L1)
- 3.2.2 Recommend appropriate therapy according to epilepsy syndrome (L2)
- 3.2.3 Recommend individualized titrations of optimal dosing for patients including starting and discontinuing medication (L1)
- 3.2.4 Communicate information regarding the antiepileptic drug regimen (L1)
- 3.2.5 Recommend second- and third-line treatments as necessary (L2)
- 3.3.2 Define treatment strategies considering issues specific to neonates and very young children (L3)
- 3.3.5 Define treatment strategies considering genetic markers (L3)
- 3.3.7 Define treatment strategies for immune mediated causes of epilepsy and seizures (L2)
- 3.5.1 Identify patients who are drug resistant according to the current ILAE definition (L1)
- 3.6.1 Demonstrate knowledge of indications, limitations and risks for ketogenic diets (L3)
- 3.7.1 Demonstrate knowledge of indications, limitations, and risks for vagal nerve stimulation and other neuromodulation techniques (L3)
- 4.1.1 Demonstrate working knowledge of indications for pre-surgical evaluation (L1)
- 4.2.1 Describe the importance of early surgical intervention regarding neuro-developmental, cognitive, behavioral and social integration aspects (L2)
- 4.3.1 Recommend and interpret video-EEG monitoring as appropriate) (L3)
- 4.3.2 Recommend functional neuroimaging as appropriate (L3)
- 4.3.3 Recommend and interpret results of neuropsychological testing (L3)
- 4.3.4 Demonstrate working knowledge on planning implantation of intracranial electrodes (L3)
- 4.4.1 Demonstrate working knowledge of etiologies amenable to surgical treatment and their prognoses in all age groups (L2)
- 4.5.1 Demonstrate ability to integrate information from multi-modal work-up and estimate risks and benefits of surgical therapy (L3)
- 4.6.1 Demonstrate knowledge about the risks and benefits associated with drug management (L3)
- 4.6.2 Demonstrate working knowledge of post-surgical neurological and psychiatric complications (L3)
- 4.6.3 Identify situations which require consideration of repeated surgery (L3)
- 4.6.4 Identify situations which require rehabilitation following surgery (L3)
- 4.7.1 Demonstrate the value and need for multidisciplinary teamwork (L3)
- 5.1.1 Articulate the conditions or elements that constitute an emergency (L1)
- 5.1.2 Appropriately manage or advise regarding prolonged or sequential seizures (L1)
- 5.2.1 Appropriately diagnose all types of convulsive status epilepticus (L1)
- 5.2.2 Appropriately diagnose all types of nonconvulsive status epilepticus including EEG interpretations
- 5.3.1 Appropriately manage all types of convulsive status epilepticus including EEG monitoring of treatment effect (L2)
- 5.3.2 Appropriately manage all types of nonconvulsive status epilepticus including EEG monitoring of treatment effect (L2)
- 6.1.1 Recognize psychiatric comorbidities, such as depression, anxiety, attention deficit and hyperactivity disorder, psychosis and autism spectrum disorders (L2)
- 6.1.2 Appropriately manage or advise regarding psychiatric comorbidities (L2)
- 6.1.3 Adjust anti-seizure treatment as required by psychiatric comorbidities (L2)
- 6.1.4 Demonstrate the ability to recognize and manage the special needs of persons with epilepsy (L3)
- 6.1.5 Manage cognitive changes in epilepsy and the cognitive effects of AEDs (L2)
- 6.2.1 Diagnose somatic comorbidities, such as those related to epilepsy treatment, causes of epilepsy, or common associated conditions (L2)
- 6.2.2 Appropriately manage and advise regarding somatic comorbidities (L2)
- 6.2.3 Adjust anti-seizure treatment as required by common somatic comorbidities (L2)
- 7.1.1 Demonstrate working knowledge of ictogenesis (L3)
- 7.2.1 Demonstrate working knowledge of epileptogenesis (L3)
- 7.3.1 Demonstrate awareness of animal models for focal and generalized epilepsies (L3)
- 7.4.1 Demonstrate knowledge of bidirectional relationship between epilepsy and psychiatric comorbidities (L3)
Subscribe to the ILAE Newsletter
To subscribe, please click on the button below.
Please send me information about ILAE activities and other
information of interest to the epilepsy community